Tumour mutational burden as a predictive and prognostic biomarker in locally advanced and recurrent/metastatic adenoid cystic carcinoma
Affiliation
The Christie Hospital NHS Foundation Trust, ManchesterIssue Date
2023
Metadata
Show full item recordCitation
Patel K, Rack S, Mistry H, Heathcote E, Betts G, Harrington KJ, et al. Tumour mutational burden as a predictive and prognostic biomarker in locally advanced and recurrent/metastatic adenoid cystic carcinoma. Journal of Clinical Oncology. 2023 Jun;41(16). PubMed PMID: WOS:001053772004086.Journal
Journal of Clinical OncologyDOI
10.1200/JCO.2023.41.16_suppl.e18086Additional Links
https://dx.doi.org/10.1200/JCO.2023.41.16_suppl.e18086Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1200/JCO.2023.41.16_suppl.e18086